Market Access Where Gross-to-net Pressure Actually Lives After Launch Drug ChannelsToday's guest post comes from Cindy Baksh, Chief Product Officer at ConnectiveRx.Read full story pharminent May 1, 2026 (Last updated: May 1, 2026) Drug Channels Today’s guest post comes from Cindy Baksh, Chief Product Officer at ConnectiveRx. Read full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: Two biotechs raise a combined $556M in latest spurt of IPOsNext: BMS brings the buzz around late-stage readouts amid a so-so Q1 Related Stories Market Access NICE aims to cut funding for Amgen lung cancer drug Lumykras pharminent July 9, 2026 Market Access UK, pharma industry pilot rapid access routes for medicines pharminent July 5, 2026 Market Access Medicare GLP-1 Bridge Launches July 1 With $50 Copays pharminent July 3, 2026
